A detailed history of Caption Management, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 435,300 shares of RZLT stock, worth $4.31 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
435,300
Previous 285,000 52.74%
Holding current value
$4.31 Million
Previous $1.27 Million 218.1%
% of portfolio
0.04%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$4.42 - $9.34 $58,339 - $123,278
-13,199 Reduced 13.2%
86,801 $806,000
Q2 2025

Aug 14, 2025

BUY
$2.47 - $4.46 $123,742 - $223,437
50,098 Added 100.39%
100,000 $446,000
Q1 2025

May 15, 2025

BUY
$2.73 - $5.57 $7,084 - $14,454
2,595 Added 5.49%
49,902 $144,000
Q4 2024

Feb 14, 2025

BUY
$4.08 - $5.96 $193,012 - $281,949
47,307 New
47,307 $225,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $385M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.